Peter Sedgwick
Direttore/Membro del Consiglio presso 3i Infrastructure (Luxembourg) Holdings SARL
Profilo
Peter Sedgwick is currently a Director at 3i Infrastructure (Luxembourg) Holdings SARL and 3i Infrastructure (Luxembourg) SARL.
Previously, he served as the Non-Executive Chairman at 3i Infrastructure Plc from 2009 to 2016.
He also served as the Chairman at Bowel Cancer UK.
Posizioni attive di Peter Sedgwick
| Società | Posizione | Inizio |
|---|---|---|
| 3i Infrastructure (Luxembourg) Holdings SARL | Direttore/Membro del Consiglio | - |
| 3i Infrastructure (Luxembourg) SARL | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter Sedgwick
| Società | Posizione | Fine |
|---|---|---|
| 3I INFRASTRUCTURE PLC | Presidente | 01/01/2016 |
Bowel Cancer UK
 Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
3i Infrastructure Plc
 3i Infrastructure Plc Investment ManagersFinance 3i Infrastructure Plc acts as a private equity fund, which invests in infrastructure businesses and assets in the UK, Europe and North America. The fund focuses on range of investment opportunities across adjacent sectors to utilities, transportation, communications and energy. It provides financing for infrastructure capital requirements. The company was founded on January 16, 2007 and is headquartered in St. Helier, the United Kingdom. | Finance |
| 3i Infrastructure (Luxembourg) Holdings SARL | |
| 3i Infrastructure (Luxembourg) SARL | |
Bowel Cancer UK
Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Miscellaneous |
- Borsa valori
- Insiders
- Peter Sedgwick
